Dr. Simon Kos
Chief Medical Officer
Dr. Simon Kos is Chief Medical Officer and Senior Director, Worldwide Health, Microsoft. In this key executive role, Dr. Kos is responsible for providing clinical guidance, thought leadership, vision and strategy for Microsoft technologies and solutions in the Health and Healthcare industries. He works with industry partners and healthcare organizations around the world to improve and transform health outcomes by leveraging technology and innovation. Dr. Kos joined Microsoft in 2010, bringing his expertise to the Australian health team after 17 years in the health and health IT industries. As the doctor on Microsoft’s health team, he was responsible for health strategy and industry engagement. He raised awareness of the Microsoft brand, technologies, and partner community, and he works to find clinical relevance for Microsoft products.
Prior to Microsoft, Dr. Kos worked with global health IT companies Cerner and InterSystems as they implemented some of the largest e-Health initiatives in Australia. Before his career in health IT, Dr. Kos practiced at NSWHealth for several years with a focus on critical care. Simon has an MBBS and a BSc (Med) from the University of New South Wales, as well as an MBA with a major in change management from the Australian Graduate School of Management. He is passionate about improving healthcare through technology.
Dr. Gene Dantkser
Qualcomm Life, Inc.
Dr. Dantsker is responsible for enabling intelligent integrated care models through the Internet of Medical Things (IoMT) in the pharmaceutical, medical device, diagnostics and payer industries. Prior to this role, Dr. Dantsker worked across the spectrum of therapy and diagnostic technology solutions with broad experience in healthcare, biotech and semiconductor businesses. Formerly, he was a senior technical staff member at TRW, Inc., Space and Electronics Division where he was responsible for design, fabrication, and integration of microelectronics for space/satellite applications.
Subsequently he co-founded Nanostream, Inc., a biotechnology company and provider of high-throughput bio-analytical instruments to pharmaceutical companies and CROs. As VP of Technology, Dr. Dantsker was co-inventor and developer of Nanostream’s core technologies based on polymer MEMS microfluidics and converted them into commercial products purchased by leading pharmaceutical companies. He also served as CEO and CTO of aDNAvance Technologies, Inc., a provider of ultra-sensitive medical molecular diagnostic products. Dr. Dantsker served on the Board of Directors of D-Wave Systems, a pioneer in Quantum Computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy, growth strategy and operational infrastructure.
Associate Director, Office of Device Evaluation, Center for Devices and Radiologic Health
U.S. Food and Drug Administration
Linda Ricci began her career developing artificial intelligence solutions in the defense industry before moving to the medical device industry as a software engineer. She helped to develop several diagnostic cardiology devices and has participated in all phases of product life cycle development. Ms. Ricci moved to the FDA in 2005 and has had several roles including scientific reviewer and branch chief within the Division of Cardiovascular devices. Currently Ms. Ricci is the Associate Director for Digital Health within the Office of Device Evaluation. In this role she, leads the development and implementation of digital health policy within the Office of Device Evaluation. She has degrees in Electrical Engineering and Medical Engineering.
Chief Commercial and Strategy Officer
Peyton Howell joined PAREXEL as Chief Commercial and Strategy Officer in May 2018 and is responsible for leading PAREXEL’s commercial operations to enhance the customer experience. Ms. Howell’s distinguished career spans over 25 years of delivering solutions that meet the needs of customers in the healthcare industry.
Ms. Howell previously held several leadership positions with AmerisourceBergen as Executive Vice President and President, Health Systems and Specialty Care Solutions, leading a business unit with market leading share of specialty and biotech products and solutions to physicians, health systems and specialty pharmacy customers. Prior to that, she served as Executive Vice President and President, Global Sourcing and Manufacturer Relations, in which she led all pharmaceutical manufacturer procurement strategy for AmerisourceBergen, including multi-billion dollar sourcing activities.
President, PAREXEL Informatics
Xavier Flinois has more than 25 years of experience in the technology and healthcare IT sectors. Since 2013, he has led PAREXEL in developing industry-leading technological innovations and solutions to enhance drug development aimed at making the process faster, more accurate, more productive and easier to track. Most recently, Mr. Flinois drove PAREXEL’s technology development alliance with Microsoft.
Mr. Flinois also led the launch of Perceptive® Cloud, a platform delivering PAREXEL solutions on an enhanced, global, secure cloud infrastructure. In addition, Mr. Flinois spearheaded the development and launch of PAREXEL’s Patient Sensor Solution and drove the Company’s collaboration with Sanofi, both with the goal of advancing the use of wearable devices to transform data collection in clinical trials.